Alexander Bagaev

Alexander Bagaev began their work experience as a Student Researcher at the Institute of Immunology in Moscow in 2011. From 2012 to 2014, they worked as a Biochemist at NTpharma. In 2013, they were a Researcher at The Institute for Molecular Medicine. Alexander then joined the University of Pennsylvania as a Researcher in 2014. In 2015, Bagaev worked as a PhD Researcher at FGBO "GNC Immunology" FMBA Russia and also as a PhD Graduate Student at Moscow State University. Alexander joined BostonGene in 2016 and held various positions, including Immunology, Tumor Microenvironment Analyst, Immunology Team Lead, and Head of Molecular Oncology. Currently, they are serving as the Vice President of Product Development at BostonGene, starting in May 2022.

Alexander Bagaev holds a Master's degree in biophysics from Lomonosov Moscow State University (MSU). Alexander pursued this degree from 2009 to 2015. Prior to obtaining their Master's degree, Alexander also completed a Doctor of Philosophy (PhD) in Immunology from the Institute of Immunology. Exact dates of their PhD program are not provided.